Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis.
To evaluate the results of percutaneous endoscopic treatment of renal pelvic transitional cell carcinoma (TCC). Ten patients (median age, 70 years; range 56-86) with a renal pelvic TCC were treated by percutaneous endoscopic resection. Seven had a normal contralateral kidney and were treated electively. Follow-up was from 3 to 77 months. There was one recurrence locally and one recurrence in the bladder. There have been no recurrences in the nephrostomy tract. We have shown that percutaneous resection of intrarenal TCC is a possible and safe technique. Further follow-up is needed to confirm its safety.